Privi Speciality Chemicals Limited (NSE:PRIVISCL)
India · Delayed Price · Currency is INR 3,676.50
-36.10 (-0.97%)
Jul 17, 2026, 3:29 PM IST
NSE:PRIVISCL Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 25,637 | 21,012 | 17,522 | 16,078 | 14,037 | |
Revenue Growth (YoY) | 22.01% | 19.91% | 8.98% | 14.54% | 9.96% |
Cost of Revenue | 15,132 | 13,001 | 11,612 | 11,281 | 9,466 |
Gross Profit | 10,505 | 8,011 | 5,910 | 4,797 | 4,571 |
Selling, General & Admin | 1,147 | 865.11 | 727.36 | 796.88 | 766.85 |
Other Operating Expenses | 2,895 | 2,609 | 1,930 | 2,135 | 1,866 |
Operating Expenses | 5,481 | 4,791 | 3,892 | 4,016 | 3,380 |
Operating Income | 5,025 | 3,219 | 2,018 | 780.79 | 1,192 |
Interest Expense | -819.54 | -878.83 | -979.39 | -678.13 | -241.13 |
Interest & Investment Income | 5.13 | 38.67 | 3.22 | 2.82 | 2.99 |
Currency Exchange Gain (Loss) | 160.46 | 122.57 | 188.28 | 182.08 | 295 |
Other Non Operating Income (Expenses) | 18.35 | 22.04 | 24.16 | 22.37 | 10 |
EBT Excluding Unusual Items | 4,389 | 2,524 | 1,254 | 309.94 | 1,259 |
Gain (Loss) on Sale of Investments | 3.85 | 11.31 | 25.45 | 6.18 | 0.03 |
Gain (Loss) on Sale of Assets | -0.43 | 4.53 | 19.32 | -5.94 | 0.07 |
Other Unusual Items | 4.58 | 5.49 | - | 0.26 | -163.26 |
Pretax Income | 4,397 | 2,545 | 1,299 | 310.43 | 1,328 |
Income Tax Expense | 1,230 | 697.73 | 344.8 | 97.65 | 353.74 |
Earnings From Continuing Operations | 3,167 | 1,848 | 954.3 | 212.78 | 973.8 |
Minority Interest in Earnings | 108.16 | 22.46 | -5.22 | 9.37 | - |
Net Income | 3,275 | 1,870 | 949.07 | 222.15 | 973.8 |
Net Income to Common | 3,275 | 1,870 | 949.07 | 222.15 | 973.8 |
Net Income Growth | 75.16% | 97.03% | 327.23% | -77.19% | -16.70% |
Shares Outstanding (Basic) | 39 | 39 | 39 | 39 | 39 |
Shares Outstanding (Diluted) | 39 | 39 | 39 | 39 | 39 |
EPS (Basic) | 83.85 | 47.87 | 24.30 | 5.69 | 24.93 |
EPS (Diluted) | 83.85 | 47.87 | 24.30 | 5.69 | 24.93 |
EPS Growth | 75.16% | 97.03% | 327.23% | -77.19% | -16.70% |
Free Cash Flow | 2,301 | -180.27 | 2,040 | -909.33 | -3,039 |
Free Cash Flow Per Share | 58.90 | -4.62 | 52.22 | -23.28 | -77.80 |
Dividend Per Share | 10.000 | 5.000 | 2.000 | - | 2.000 |
Dividend Growth | 100.00% | 150.00% | - | - | - |
Gross Margin | 40.98% | 38.13% | 33.73% | 29.84% | 32.57% |
Operating Margin | 19.60% | 15.32% | 11.52% | 4.86% | 8.49% |
Profit Margin | 12.78% | 8.90% | 5.42% | 1.38% | 6.94% |
Free Cash Flow Margin | 8.97% | -0.86% | 11.64% | -5.66% | -21.65% |
EBITDA | 6,371 | 4,463 | 3,175 | 1,787 | 1,903 |
EBITDA Margin | 24.85% | 21.24% | 18.12% | 11.11% | 13.56% |
D&A For EBITDA | 1,346 | 1,243 | 1,157 | 1,006 | 711.28 |
EBIT | 5,025 | 3,219 | 2,018 | 780.79 | 1,192 |
EBIT Margin | 19.60% | 15.32% | 11.52% | 4.86% | 8.49% |
Effective Tax Rate | 27.97% | 27.41% | 26.54% | 31.46% | 26.65% |
Revenue as Reported | 25,829 | 21,218 | 17,785 | 16,292 | 14,361 |